Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of alternative mRNA splicing in cultured cell populations representing progressive stages of human fetal kidney development. | Sci Rep | 2022 | 36380228 | PubTator, text mining | PubMed |
| Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer. | Cancer Cell Int | 2022 | 36369058 | PubTator, text mining | PubMed |
| Expression, Prognostic Value, and Functional Mechanism of Polarity-Related Genes in Hepatocellular Carcinoma. | Int J Mol Sci | 2022 | 36361574 | PubTator, text mining | PubMed |
| Alterations in DNA Methylation in Orofacial Clefts. | Int J Mol Sci | 2022 | 36361518 | PubTator, text mining | PubMed |
| Associations between Motives for Physical Exercise, Body Composition and Cardiorespiratory Fitness: A Cross-Sectional Study. | Int J Environ Res Public Health | 2022 | 36361006 | PubTator, text mining | PubMed |
| Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile. | Biomedicines | 2022 | 36359251 | PubTator, text mining | PubMed |
| Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness. | Cancers (Basel) | 2022 | 36358747 | PubTator, text mining | PubMed |
| Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36358744 | PubTator, text mining | PubMed |
| Deep Learning Approaches in Histopathology. | Cancers (Basel) | 2022 | 36358683 | PubTator, text mining | PubMed |
| Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer. | BMC Cancer | 2022 | 36348290 | PubTator, text mining | PubMed |
| Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36338767 | PubTator, text mining | PubMed |
| The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy. | Front Oncol | 2022 | 36338731 | PubTator, text mining | PubMed |
| Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going. | Front Surg | 2022 | 36338621 | PubTator, text mining | PubMed |
| Somatic mutations in FAT cadherin family members constitute an underrecognized subtype of colorectal adenocarcinoma with unique clinicopathologic features. | World J Clin Oncol | 2022 | 36337316 | PubTator, text mining | PubMed |
| Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas. | Nat Commun | 2022 | 36335125 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| The emerging double-edged sword role of Sirtuins in the gastric inflammation-carcinoma sequence revealed by bulk and single-cell transcriptomes. | Front Oncol | 2022 | 36324577 | PubTator, text mining | PubMed |
| Influence of maternal body mass index on human milk composition and associations to infant metabolism and gut colonisation: MAINHEALTH - a study protocol for an observational birth cohort. | BMJ Open | 2022 | 36323479 | PubTator, text mining | PubMed |
| Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy. | J Transl Med | 2022 | 36303162 | PubTator, text mining | PubMed |
| Italian Ketogenic Mediterranean Diet in Overweight and Obese Patients with Prediabetes or Type 2 Diabetes. | Nutrients | 2022 | 36297044 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=54